Antidiabetic and antihyperlipidemic activities of Malvastrum coromandelianum Linn leaves in alloxan induced diabetic rats

International Journal of PharmTech Research

Volumn 4, Issue 1, 2012, Pages 351-357

  Deore, Amol Bhalchandra ^a   Chavan, Preetam Nivrutti ^a   Sapakal, Vinayak Dnyandev ^a   Naikwade, Nilofar S ^a  

^a Appasaheb Birnale College of Pharmacy   (India)

Author keywords

Alloxan; Fasting blood glucose; HDL cholesterol; Total cholesterol; Triglyceride

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MALVASTRUM COROMANDELIANUM EXTRACT; PIOGLITAZONE; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ANTIHYPERLIPIDEMIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; MALVASTRUM COROMANDELIANUM; MEDICINAL PLANT; NONHUMAN; PLANT LEAF; RAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84859993305     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Baynes J. W., Role of oxidative stress in development of complications in diabetes, Diabetes. 1991,40, 405-412.
2. Brownlee M., and Cerami A., The biochemistry of the complications of diabetes mellitus, Ann. Rev. Biochem. 1981,50, 385-432.
3. Meinders A. E., and Kuyvenhoven J. P., Review article Oxidative stress and diabetes mellitus Pathogenesis of long-term complications, Eur. J Inter. Med. 1999,10, 9-19.
4. Nagappa A. N., Thakurdesai P. A., Venkat Rao N., and Jiwan Singh, Antidiabetic activity of Terminalia catappa Linn fruits, J Ethnopharmacol. 2003,88, 45-50.
5. O'Brien R. M., and Granner D. K., Regulation of gene expression by insulin, Phys. Rev. 1996,76, 1109-1161.
6. King et al., Global burden of diabetes, 1995-2025, prevalence, numerical estimates, and projections, Diabetes Care. 1998, 21, 1414-1431.
7. Yajnik C. S., The insulin resistance epidemic in India, fetal origins, later lifestyle, or both? Nutr. Rev. 2001,59, 1-9.
8. Brunton L. L., Parker K. L., Blumenthal D. K., and Buxton L. O. Insulin, oral hypoglycemic agents and pharmacology of endocrine pancreas, Goodman and Gillman's Manual of pharmacology and therapeutics, The McGraw-Hill Companies, USA, 2008,1048-1068.
9. Katzung B. G., Pancreatic hormone and antidiabetic drugs. Basic & Clinical Pharmacology, edited by Bertram G. Katzung, 10th Edition, McGraw Hill, USA,2007, 683-705.
10. Bailey L. J., and Day C., Traditional plant medicine as treatment for diabetes, Diabetes Care. 1989,12, 553-564.
11. Fyson P. F., The flora of the Nilgiris and Pulney Hill Tops, Volume I. 1st ed. Dehra Dun, India, Bishen singh Mahendra Pal Singh, 1974.
12. Kirtikar K. R., and Basu B. D., Indian medicinal plants, International Book Distributors and Publishers, Dehra Dun, India, 1995.
13. Khonsung P., Nantsupawat S., Jesadanont S. N., Chantharateptawan V., and Panthong A., Antiinflammatory and analgesic activities of water extract of Malvastrum coromandelianum (L.) Garcke, Thai. J Pharmacol. 2006, 28(03).
14. Reddy Y. S. R., Sama V., and Suresh B., Antinociceptive activity of Malvastrum coromandelinum, Fitoterapia. 2001, 72(3),278-280.
15. Rattanajarasroj S., Bansiddhi J., Kun-Anek A., and Chaorai B., Hypoglycemic activity of daikhad (Malvastrum coromandelianum (L.) Garcke) in rats, Bull. Dept. Med. Sci., 2005,180.
16. Srinivasan K., and Ramarao P., Animal models in type 2 diabetes research, an overview, Ind. J. Med. Res. 2007,125,451-472.
17. Katsumata K., Katsumata K., and Katsumata Y. Protective effect of diltiazem hydrochloride on the occurrence of alloxan or streptozotocin induced diabetes in rats, Hor. Met. Res. J., 1992, 24, 508-510.
18. Szkudelski T., The Mechanism of Alloxan and Streptozotocin Action in B Cells of the Rat Pancreas, Phys. Res. 50, 2001,536-546.
19. Kannur D. M., Hukkeri V. I., and Akki K. S., Antidiabetic activity of Caesalpinia bonducella seed extracts in rats, Fitoterapia 2006,77, 546-549.
20. Kliber A., Szkudelski T., and Chichlowska J., Alloxan stimulation and subsequent inhibition of insulin release rom in situ perfused rat pancreas, J. Phys. Pharmacol, 1996,47,321-328.
21. Sushruta K., Satyanarayana S., and Srinivas N., Evaluation of the blood-glucose reducing effects of aqueous extracts of the selected umbelliferous fruits used in culinary practices, Trop. J. Pharma. Res. 2006,5(2), 613-617.
22. Roeschlau P., Bernt E., and Gruber W., Enzymatic determination of total cholesterol in serum, Zeitschrift fur Klinische Chemie und Klinische Biochemie. 1974,12, 226.
23. Buccolo G., and David M., Quantitative determination of serum triglycerides by use of enzyme, Clin. Chem. 1973,19, 476-482.
24. Friedwald J., Levy Y. R., and Friedrickson S. D., Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge, Clin. Chem. 1972,18, 499-502.
25. Punitha R., and Manoharan S., Antihyperglycemic and antilipidperoxidative effects of Pongamia pinnata (Linn.) Pierre flowers in alloxan induced diabetic rats, J. Ethnopharmacol. 2006,105, 39-46.
26. th edition, Saunders,2008.
27. Davidson M. B., Diabtes Mellitus Diagnosis and Treatment, Wiley, New York, 1981.
28. Rhoads G. G., Gulbrandse C. L., and Kagen A. Serum lipoprotein and coronary artery disease in a population study of Hawaiian Japanese men, N. Eng. J. Med. 1976, 294,293-298.
29. Sakurai K., Katoh M., Someno K., and Fujimoto Y., Apoptosis and mitochondrial damage in INS-1 cells treated with alloxan, Bio. Pharm. Bull. 2001, 24, 876-882.